Pharmaceutical Execs Brace for Earnings Turbulence: How Tariffs and Regulatory Changes Could Impact Drug Markets Frank Dolan April 16, 2025
Third Harmonic Bio to Liquidate: What This Means for Biotech Investors and Future Therapies Frank Dolan April 15, 2025
Pfizer Halts Danuglipron: What This Means for the Future of Obesity Treatments Frank Dolan April 15, 2025
U.S. Commerce Department Launches Investigation into Pharmaceutical Imports: Are Tariffs on the Horizon? Frank Dolan April 15, 2025
Bristol Myers Squibb’s Camzyos Faces Major Setback: What It Means for Heart Health and Drug Development Frank Dolan April 15, 2025
Unraveling the Controversial HHS Layoffs: Legal Challenges and Employee Rights at Stake Frank Dolan April 15, 2025
Johnson & Johnson Defies Tariff Challenges: Earnings Resilience and Bold Investments for the Future Frank Dolan April 15, 2025
Bipartisan Coalition of 39 Attorneys General Calls for Legislation to Separate Pharmacy Benefit Managers from Pharmacies Frank Dolan April 15, 2025
U.S. Commerce Department Investigates Pharma Imports: Are Tariffs on Medications Coming? Frank Dolan April 15, 2025
Merck Partners with Cyprumed: A $493M Deal Revolutionizing Oral Peptide Delivery Frank Dolan April 15, 2025
NTEU and HHS Engage in Negotiations for Reinstating FDA Employees: What’s Next? Frank Dolan April 14, 2025
Revolutionizing Drug-Gene Interactions: How QIAGEN’s PGXI Platform Transforms Pharmacogenomics with Evidence-Based Databases Frank Dolan April 14, 2025
Navigating Challenges in Biotech: Strategies, Tariffs, and Legislative Boosts You Need to Know Frank Dolan April 12, 2025
Revolutionary Cancer Treatment: Bristol Myers Squibb’s Opdivo and Yervoy Approved for First-Line Use in Liver and Colorectal Cancer Frank Dolan April 11, 2025
Novartis Invests $23 Billion in U.S. Manufacturing: A Game-Changer for Domestic Drug Production Frank Dolan April 11, 2025
FDA Reverses Full-Time Office Mandate: Remote Work Flexibility Takes Center Stage Frank Dolan April 11, 2025
Brace for Impact: How Trump’s Potential Pharma Tariffs Could Transform Drug Pricing and Distribution Frank Dolan April 10, 2025
Federal Appeals Court Clears Way for HHS to Terminate Probationary Employees: What It Means for Job Security in Government Frank Dolan April 10, 2025
Unlocking Access: ICER’s Game-Changing Solutions for Affordable GLP-1 Medications in Obesity Treatment Frank Dolan April 9, 2025
